European Union Device Regulation (EU MDR)

Website https://www.compliance4alllearning.com/webinar/european-union-device-regulation-(eu-mdr)--503875LIVE | Edit Freely

Category

Deadline: August 10, 2021 | Date: August 10, 2021

Venue/Country: Online event, U.S.A

Updated: 2021-06-23 22:25:10 (GMT+9)

Call For Papers - CFP

The EU MDR replaces the MDD and expands the requirements for conformance. The MDR contains 174 pages with 123 "Articles" in 10 "Chapters" and 17 "Annexes".

In contrast the MDD has 60 pages. New requirements are added and existing requirements are expanded. The MDR is effective May 2020 leaving limited time to prepare.

These new and expanded requirements will be explained. Attendees should have a reasonable understanding of FDA regulations.

Why you should Attend: The EU MDR will be effective in May 2020. Products intended to be imported into the EU must conform to these new regulations. Arrangements must be made with a Notified Body, an Authorized Representative and a Person Responsible for Regulatory Compliance.

There is extensive preparation necessary. This webinar will explain what needs to be done to meet the deadline.

Areas Covered in the Session:

EU MDR objectives

QMS requirements

Device classification changes

Documentation requirements

Clinical evaluation requirements

UDI and labelling requirements

Post market surveillance

New Notified Body obligations

Human Factors/ Usability requirements

Who Will Benefit:

Engineers

Regulatory personnel

Quality Assurance personnel

Marketing

Management

Importers of medical devices

Distributors of medical devices

Speaker Profile

Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.